BIONOVAX has new and innovative processes to manufacture high quality Heparin Active Pharmaceutical Ingredient - Heparin Sodium, Heparin Lithium, Heparinoid, and related derivative products. The purification of heparin from offal tissue is an old industrial process for which commercial recipes date back to 1922. Although chemical, chemoenzymatic, and biotechnological alternatives for this production method have been published in the academic literature, animal-tissue is still the sole source for commercial heparin production in industry.
BIONOVAX’s Heparin Active Pharmaceutical Ingredients are not contaminated from Aphthae epizooticae, foot-and-mouth disease (FMD) and free from “African swine fever” because of our government good epidemic prevention. We are the best resource for Heparin API in the whole world.
Now, BIONOVAX will offer the best quality Heparin active pharmaceutical ingredient and its derivates; and Low Molecular Weight Heparin active pharmaceutical ingredient. These are completed to meet the demand among in the family of nations. Please contact: vincentwu@bionovax.com
News